SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,322 | -54.1% | 111,900 | -7.6% | 0.00% | -100.0% |
Q2 2023 | $580,112 | -10.1% | 121,109 | +6.5% | 0.00% | 0.0% |
Q1 2023 | $645,008 | +0.7% | 113,758 | -0.5% | 0.00% | 0.0% |
Q4 2022 | $640,282 | -11.8% | 114,336 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $726,000 | +152.1% | 113,150 | +34.8% | 0.00% | – |
Q2 2022 | $288,000 | -54.1% | 83,944 | -4.9% | 0.00% | -100.0% |
Q1 2022 | $628,000 | -21.5% | 88,234 | -8.1% | 0.00% | 0.0% |
Q4 2021 | $800,000 | +22.3% | 96,007 | +2.1% | 0.00% | 0.0% |
Q3 2021 | $654,000 | -71.4% | 94,000 | -2.0% | 0.00% | -66.7% |
Q2 2021 | $2,289,000 | +33.5% | 95,966 | +15.2% | 0.00% | +50.0% |
Q1 2021 | $1,715,000 | -16.2% | 83,283 | -0.3% | 0.00% | -33.3% |
Q4 2020 | $2,047,000 | -10.0% | 83,534 | +4.0% | 0.00% | -25.0% |
Q3 2020 | $2,275,000 | +622.2% | 80,349 | +21.3% | 0.00% | +300.0% |
Q2 2020 | $315,000 | +53.7% | 66,253 | +15.2% | 0.00% | – |
Q1 2020 | $205,000 | +4.6% | 57,493 | +1.1% | 0.00% | – |
Q4 2019 | $196,000 | -14.0% | 56,844 | 0.0% | 0.00% | – |
Q3 2019 | $228,000 | +115.1% | 56,844 | +72.3% | 0.00% | – |
Q2 2019 | $106,000 | -53.3% | 32,982 | 0.0% | 0.00% | – |
Q1 2019 | $227,000 | +52.3% | 32,982 | 0.0% | 0.00% | – |
Q4 2018 | $149,000 | -37.9% | 32,982 | +4.3% | 0.00% | – |
Q3 2018 | $240,000 | -11.8% | 31,612 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $272,000 | +17.2% | 31,612 | 0.0% | 0.00% | – |
Q1 2018 | $232,000 | -29.7% | 31,612 | -3.0% | 0.00% | -100.0% |
Q4 2017 | $330,000 | -36.9% | 32,581 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $523,000 | +27.6% | 32,581 | -10.2% | 0.00% | 0.0% |
Q2 2017 | $410,000 | +1.5% | 36,280 | +1.1% | 0.00% | 0.0% |
Q1 2017 | $404,000 | +11.3% | 35,880 | -2.2% | 0.00% | 0.0% |
Q4 2016 | $363,000 | -21.6% | 36,680 | -2.7% | 0.00% | 0.0% |
Q3 2016 | $463,000 | -57.4% | 37,680 | +0.8% | 0.00% | -50.0% |
Q2 2016 | $1,086,000 | +125.3% | 37,380 | +106.0% | 0.00% | +100.0% |
Q1 2016 | $482,000 | -13.8% | 18,147 | +14.0% | 0.00% | 0.0% |
Q4 2015 | $559,000 | +21.0% | 15,919 | +2.0% | 0.00% | 0.0% |
Q3 2015 | $462,000 | – | 15,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
Geduld E E | 15,000 | $149,000 | 0.08% |
Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |